Entity
  • Neocor Therapeutics

    Created in 2023
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    98
  • Activities

  • Technologies

  • Entity types

  • Location

    17 Av. Franklin Roosevelt, 13600 La Ciotat, France

    La Ciotat

    France

  • Employees

    Scale: 2-10

    Estimated: 4

  • Engaged corporates

    1
    0 0
  • Added in Motherbase

    1 month, 1 week ago
Description
  • Value proposition

    Neocor is dedicated to pioneering transformative therapies in cardiac care

    We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials.
    The Company was founded in October and has received strong traction since inception.
    We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.

    gene therapy, biotechnology, rare disease, and cardiology

  • Original language

    Neocor is dedicated to pioneering transformative therapies in cardiac care

    We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials.
    The Company was founded in October and has received strong traction since inception.
    We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials.

Corporate interactions BETA
Corporate TypeTweets Articles
SATT Sud-Est
SATT Sud-Est
Research, National and local authorities, Research Services
SATT Sud-Est
Research, National and local authorities, Research Services
Other

10 Jul 2024


Similar entities
Loading...
Loading...
Social network dynamics